KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Cash from Operations (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Cash from Operations for 17 consecutive years, with 164900000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 32.77% to 164900000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 532200000.0 through Dec 2025, up 16.92% year-over-year, with the annual reading at 532200000.0 for FY2025, 16.92% up from the prior year.
  • Cash from Operations for Q4 2025 was 164900000.0 at Bio-Rad Laboratories, up from 120900000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 230363000.0 in Q3 2021, with the low at 10990000.0 in Q3 2022.
  • Average Cash from Operations over 5 years is 111310000.0, with a median of 105850000.0 recorded in 2021.
  • The sharpest move saw Cash from Operations crashed 95.23% in 2022, then skyrocketed 789.13% in 2023.
  • Over 5 years, Cash from Operations stood at 170903000.0 in 2021, then plummeted by 53.42% to 79610000.0 in 2022, then grew by 1.75% to 81000000.0 in 2023, then soared by 53.33% to 124200000.0 in 2024, then skyrocketed by 32.77% to 164900000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 164900000.0, 120900000.0, and 116500000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.